AAAAAA
Results:
1-10
|
Results: 10
Authors:
SAMELIS GF
MOULAKAKIS A
NAKOS S
SKOUNAKIS M
ELEFSINIOTIS J
LAFIATIS J
CHRISTOFORATOS T
KARVOUNTZIS G
Citation: Gf. Samelis et al., SURVIVAL BENEFIT WITH IMMUNOCHEMOTHERAPY IN THE TREATMENT OF UNRESECTABLE HEPATOCELLULAR CANCER (HCC), Annals of oncology, 9, 1998, pp. 250-250
Authors:
MAVROGIANNIS C
LIATSOS C
ROMANOS A
PETOUMENOS C
NAKOS A
KARVOUNTZIS G
Citation: C. Mavrogiannis et al., NEEDLE KNIFE FISTULOTOMY VERSUS NEEDLE KNIFE PRECUT PAPILLOTOMY FOR THE TREATMENT OF COMMON BILE-DUCT STONES, Gastrointestinal endoscopy, 47(4), 1998, pp. 391-391
Authors:
MAVROGIANNIS C
LIATSOS C
ROMANOS A
GOULAS S
NAKOS A
KARVOUNTZIS G
Citation: C. Mavrogiannis et al., SHORT-TERM AND LONG-TERM RESULTS AFTER ENDOSCOPIC TREATMENT IN PATIENTS WITH BILIARY SUMP SYNDROME, Gastroenterology, 114(4), 1998, pp. 2166-2166
Authors:
TASSOPOULOS NC
KARVOUNTZIS G
TSANTOULAS D
VAFIADI E
HATZIS G
AKRIVIADIS E
SKOUTELIS A
SIMOS A
KEHAGIOGLOU K
DELLADETSIMA I
DEMONAKOU M
KATSOULIDOU A
SYPSA V
HATZAKIS A
Citation: Nc. Tassopoulos et al., A MULTICENTER RANDOMIZED TRIAL OF 6-24 MONTH A-IFN THERAPY OF CHRONICHEPATITIS-C (CHC) DIRECTED BY SERUM HCV RNA - FIRST INTERIM ANALYSIS, Hepatology, 26(4), 1997, pp. 1939-1939
Authors:
TASSOPOULOS NC
KARVOUNTZIS G
TOULOUMI G
DELLADETSIMA J
PAPATHEODORIDIS GV
KATSOULIDOU A
RETALIS G
HATZAKIS A
Citation: Nc. Tassopoulos et al., COMPARATIVE EFFICACY OF HIGH AND LOW-DOSE OF INTERFERON ALFA-2B IN CHRONIC HEPATITIS-C - A RANDOMIZED CONTROLLED TRIAL, Hepatology, 23(1), 1996, pp. 67-67
Authors:
HATZAKIS A
KATSOULIDOU A
KAKLAMANI E
TOULOUMI G
KOUMANTAKI Y
TASSOPOULOS NC
KARVOUNTZIS G
GIOUSTOZI A
HADZIYANNIS S
TRICHOPOULOS D
Citation: A. Hatzakis et al., HEPATITIS-C VIRUS 1B IS THE DOMINANT GENOTYPE IN HCV-RELATED CARCINOGENESIS - A CASE-CONTROL STUDY, International journal of cancer, 68(1), 1996, pp. 51-53
Authors:
TASSOPOULOS NC
KARVOUNTZIS G
TOULOUMI G
DELLADETSIMA JK
PAPATHEODORIDIS GV
KATSOULIDOU A
RETALIS G
HATZAKIS A
Citation: Nc. Tassopoulos et al., COMPARATIVE EFFICACY OF A HIGH OR LOW-DOSE OF INTERFERON ALPHA(2B) INCHRONIC HEPATITIS-C - A RANDOMIZED CONTROLLED TRIAL, The American journal of gastroenterology, 91(9), 1996, pp. 1734-1738
Authors:
TASSOPOULOS NC
KARVOUNTZIS G
TOULOUMI G
DELLADETSIMA J
PAPATHEODORIDIS GV
KATSOULIDOU A
RETALIS G
HATZAKIS A
Citation: Nc. Tassopoulos et al., COMPARATIVE EFFICACY OF HIGH AND LOW-DOSE OF INTERFERON ALFA-2B IN CHRONIC HEPATITIS-C - A RANDOMIZED CONTROLLED TRIAL, Hepatology, 22(4), 1995, pp. 32-32
Authors:
TASSOPOULOS NC
HATZAKIS AE
PAPATHEODORIDIS GV
KARVOUNTZIS G
TROONEN H
LENNARTZ L
Citation: Nc. Tassopoulos et al., EARLY PREDICTION OF SUCCESSFUL ALPHA-INTERFERON THERAPY OF CHRONIC HEPATITIS-C BY CORE-IGM ANTIBODIES TO HEPATITIS-C VIRUS, Journal of hepatology, 20(2), 1994, pp. 305-306
Authors:
DIMOPOULOU M
FAFOUTIS K
BASILIOU K
KETIKOGLOU J
KARVOUNTZIS G
Citation: M. Dimopoulou et al., INTERFERON-ALFA-2B FOR DECOMPENSATED LIVER-DISEASE CAUSED BY EITHER CHRONIC HEPATITIS-B OR HEPATITIS-C - PRELIMINARY-RESULTS OF A PILOT-STUDY, Gut, 34(2), 1993, pp. 104-105
Risultati:
1-10
|